← Leaderboards
Kelsey R Thomas
Va San Diego Healthcare System
$2,520,641
Attributed
$2,740,012
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2020–24$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,740,012 · 3
VA$0 · 1
By mechanism
RF1$2,095,206 · 1
R03$644,806 · 2
IK2$0 · 1
Top collaborators
- Alexandra Leigh Clark1 shared
- Michael Marsiske1 shared
Most similar at Va San Diego Healthcare System
Same institution · by research overlap
- Royce Ellen Clifford$2,000,724
- Matthew Herbert$1,442,004
- Chelsea Hays$0
- Tara Austin$0
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCognitiveNeuroimagingPathologicImpaired CognitionMild Cognitive ImpairmentDiagnosisNeuropsychologyDementiaBiological MarkersFutureEarly IdentificationFunctional DeclineWhite Matter HyperintensityAttentionTau ProteinsPerformanceCognitive ChangeAlzheimerâS Disease BiomarkerS DiseaseRecruitBiologicalCare CostsCost
Grant awards (10)
Heterogeneity of subtle cognitive decline phenotypes in community-dwelling older adults$257,006
RF1 · FY2024 · AG · contact PI
Impact of Diabetes on Cognitive and Perfusion Inefficiencies in Preclinical AD$0
IK2 · FY2024 · VA · contact PI
Heterogeneity of subtle cognitive decline phenotypes in community-dwelling older adults$1,838,200
RF1 · FY2023 · AG · contact PI
The impact of segregation and the mediating effects of vascular risk on 10-year cognitive and functional outcomes in Black/African American older adults enrolled in the ACTIVE study$329,056
R03 · FY2023 · AG
Impact of Diabetes on Cognitive and Perfusion Inefficiencies in Preclinical AD$0
IK2 · FY2023 · VA · contact PI
Identifying best methods for the detection of subtle cognitive decline$158,000
R03 · FY2022 · AG · contact PI
Impact of Diabetes on Cognitive and Perfusion Inefficiencies in Preclinical AD$0
IK2 · FY2022 · VA · contact PI
Identifying best methods for the detection of subtle cognitive decline$157,750
R03 · FY2021 · AG · contact PI
Impact of Diabetes on Cognitive and Perfusion Inefficiencies in Preclinical AD$0
IK2 · FY2021 · VA · contact PI
Impact of Diabetes on Cognitive and Perfusion Inefficiencies in Preclinical AD$0
IK2 · FY2020 · VA · contact PI